Related Experiment Video
Updated: Apr 25, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Mutation analysis of patients with neurodegenerative disorders using NeuroX array
Mahdi Ghani1, Anthony E Lang2, Lorne Zinman3
1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
The NeuroX array enables rapid genetic screening for neurodegenerative diseases, identifying causative mutations in Alzheimer's and ALS patients. This cost-effective tool aids in diagnosing rare damaging variants, improving mutation analysis efficiency.
Area of Science:
- Genetics
- Neuroscience
- Genomic Medicine
Background:
- Genetic mutations are key in neurodegenerative disorders.
- Sanger sequencing for mutation analysis is slow and expensive.
Purpose of the Study:
- Evaluate the NeuroX array for efficient mutation screening in neurodegenerative diseases.
- Identify rare damaging variants in genes associated with these conditions.
Main Methods:
- Utilized a semi-custom genome-wide array (NeuroX) for genetic analysis.
- Investigated 192 patients across 4 neurodegenerative disorders.
- Analyzed 77 disease-implicated genes for rare damaging variants.
Main Results:
- Identified causative mutations, including PSEN1 in Alzheimer's and SOD1 in ALS.
- Detected 78 rare damaging variants (<1% frequency).
- Found LRRK2 p.R1514Q in 6.1% of Parkinson's disease patients.
Conclusions:
- The NeuroX array is effective for rapid and accurate mutation screening in neurodegenerative diseases.
- The array identified significant causative mutations and rare variants.
- Further development may enhance the array's capabilities.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018